Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
This study has been terminated.
Sponsor:
SGX Pharmaceuticals, Inc.
Information provided by:
SGX Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00606879
First received: January 18, 2008
Last updated: July 22, 2008
Last verified: July 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | June 2009 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |